Clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Oh, Sung ^a   Kwon, Hyuk Chan ^a   Kim, Sung Hyun ^a   Jang, Jin Seok ^a   Kim, Min Chan ^a   Kim, Kyeong Hee ^a   Han, Jin Yeong ^a   Kim, Chung ^a   Kim, Su Jin ^a   Jeong, Jin Sook ^a   Kim, Hyo Jin ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53; VASCULOTROPIN; TUMOR MARKER; VASCULOTROPIN A;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STOMACH CANCER; ADENOCARCINOMA; BIOSYNTHESIS; BLOOD; CANCER STAGING; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; STOMACH TUMOR; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 44649198327     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-123     Document Type: Article

References (31)

1. Liao D Johnson RS Hypoxia: A key regulator of angiogenesis in cancer Cancer Metastasis Rev 2007, 26(2):281-290. 10.1007/s10555-007-9066-y 17603752
2. Maxwell PH Dachs GU Gleadle JM Nicholls LG Harris AL Stratford IJ Hankinson O Pugh CW Ratcliffe PJ Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth Proc Natl Acad Sci USA 1997, 94(15):8104-8109. 21564 9223322 10.1073/pnas.94.15.8104
3. Wenger RH Camenisch G Desbaillets I Chilov D Gassmann M Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction Cancer Res 1998, 58(24):5678-5680. 9865721
4. Seagroves TN Ryan HE Lu H Wouters BG Knapp M Thibault P Laderoute K Johnson RS Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells Mol Cell Biol 2001, 21(10):3436-3444. 100265 11313469 10.1128/MCB.21.10.3436-3444.2001
5. Akakura N Kobayashi M Horiuchi I Suzuki A Wang J Chen J Niizeki H Kawamura K Hosokawa M Asaka M Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation Cancer Res 2001, 61(17):6548-6554. 11522653
6. Graeber TG Peterson JF Tsai M Monica K Fornace AJ Jr Giaccia AJ Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status Mol Cell Biol 1994, 14(9):6264-6277. 359153 8065358
7. Graeber TG Osmanian C Jacks T Housman DE Koch CJ Lowe SW Giaccia AJ Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 1996, 379(6560):88-91. 10.1038/379088a0 8538748
8. Baas IO Hruban RH Offerhaus GJ Clinical applications of detecting dysfunctional p53 tumor suppressor protein Histol Histopathol 1999, 14(1):279-284. 9987672
9. Frederick LG Stomach American Joint Committee on Cancer. AJCC Cancer Staging Manual Philadelphia: Lippincott-Raven 6 2002. 99-106.
10. Roskoski R Jr Vascular endothelial growth factor (VEGF) signaling in tumor progression Crit Rev Oncol Hematol 2007, 62(3):179-213. 10.1016/ j.critrevonc.2007.01.006 17324579
11. Zagzag D Zhong H Scalzitti JM Laughner E Simons JW Semenza GL Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression Cancer 2000, 88(11):2606-2618. 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W 10861440
12. Theodoropoulos VE Lazaris A Sofras F Gerzelis I Tsoukala V Ghikonti I Manikas K Kastriotis I Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer Eur Urol 2004, 46(2):200-208. 10.1016/j.eururo.2004.04.008 15245814
13. Bos R Zhong H Hanrahan CF Mommers EC Semenza GL Pinedo HM Abeloff MD Simons JW van Diest PJ Wall van der E Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis J Natl Cancer Inst 2001, 93(4):309-314. 10.1093/jnci/93.4.309 11181778
14. Kuwai T Kitadai Y Tanaka S Onogawa S Matsutani N Kaio E Ito M Chayama K Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma Int J Cancer 2003, 105(2):176-181. 10.1002/ijc.11068 12673675
15. Nakayama K Kanzaki A Hata K Katabuchi H Okamura H Miyazaki K Fukumoto M Takebayashi Y Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma Cancer Lett 2002, 176(2):215-223. 10.1016/S0304-3835(01)00762-5 11804750
16. Wiesener MS Munchenhagen PM Berger I Morgan NV Roigas J Schwiertz A Jurgensen JS Gruber G Maxwell PH Loning SA Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas Cancer Res 2001, 61(13):5215-5222. 11431362
17. Saramaki OR Savinainen KJ Nupponen NN Bratt O Visakorpi T Amplification of hypoxia-inducible factor 1alpha gene in prostate cancer Cancer Genet Cytogenet 2001, 128(1):31-34. 10.1016/S0165-4608(01)00396-X 1145442
18. Aebersold DM Burri P Beer KT Laissue J Djonov V Greiner RH Semenza GL Expression of hypoxia-inducible factor-1alpha: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer Cancer Res 2001, 61(7):2911-2916. 11306467
19. Birner P Schindl M Obermair A Breitenecker G Oberhuber G Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: Its impact on prognosis and on response to chemotherapy Clin Cancer Res 2001, 7(6):1661-1668. 11410504
20. Hashimoto H Akimoto M Maeda A Shigemoto M Yamashito K Relation of Hypoxia-Inducible Factor-1alpha to Vascular Endothelial Growth Factor and Vasoactive Factors During Healing of Gastric Ulcers J Cardiovasc Pharmacol 2004, 44:S407-S409. 10.1097/01.fjc.0000166305.79055.ad 15838334
21. Fondevila C Metges JP Fuster J Grau JJ Palacin A Castells A Volant A Pera M p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer Br J Cancer 2004, 90(1):206-215. 10.1038/sj.bjc.6601455 14710231
22. Gomyo Y Ikeda M Osaki M Tatebe S Tsujitani S Ikeguchi M Kaibara N Ito H Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma Cancer 1997, 79(11):2067-2072. 10.1002/ (SICI)1097-0142(19970601)79:11<2067::AID-CNCR3>3.0.CO;2-M 9179052
23. Poon RT Fan ST Wong J Clinical implications of circulating angiogenic factors in cancer patients J Clin Oncol 2001, 19(4):1207-1225. 11181687
24. Baba M Konno H Maruo Y Tanaka T Kanai T Matsumoto K Matsuura M Nishino N Maruyama K Nakamura S Relationship of p53 and vascular endothelial growth factor expression of clinicopathological factors in human scirrhous gastric cancer Eur Surg Res 1998, 30(2):130-137. 10.1159/ 000008568 9565747
25. Maeda K Chung YS Ogawa Y Takatsuka S Kang SM Ogawa M Sawada T Sowa M Prognostic value of vascular endothelial growth factor expression in gastric carcinoma Cancer 1996, 77(5):858-863. 10.1002/ (SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A 8608475
26. Tanigawa N Amaya H Matsumura M Shimomatsuya T Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma J Clin Oncol 1997, 15(2):826-832. 9053510
27. Yao JC Wang L Wei D Gong W Hassan M Wu TT Mansfield P Ajani J Xie K Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer Clin Cancer Res 2004, 10(12 Pt 1):4109-4117. 10.1158/1078-0432.CCR-03-0628 15217947
28. Konno H Ohta M Baba M Suzuki S Nakamura S The role of circulating IL-8 and VEGF protein in the progression of gastric cancer Cancer Sci 2003, 94(8):735-740. 10.1111/j.1349-7006.2003.tb01511.x 12901801
29. Ohta M Konno H Tanaka T Baba M Kamiya K Syouji T Kondoh K Watanabe M Terada H Nakamura S The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer Cancer Lett 2003, 192(2):215-225. 10.1016/0304-3835(02)00681-X 12668286
30. Kim HK Song KS Park YS Kang YH Lee YJ Lee KR Ryu KW Bae JM Kim S Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: Possible role of a metastasis predictor Eur J Cancer 2003, 39(2):184-191. 10.1016/ S0959-8049(02)00596-8 12509950
31. Karayiannakis AJ Syrigos KN Polychronidis A Zbar A Kouraklis G Simopoulos C Karatzas G Circulating VEGF levels in the serum of gastric cancer patients: Correlation with pathological variables, patient survival, and tumor surgery Ann Surg 2002, 236(1):37-42. 1422546 12131083 10.1097/00000658-200207000-00007